Karyopharm Therapeutics reported $8K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Amgen AMGN:US USD 32.37B 1.03B
AstraZeneca AZN:LN USD 387M 0
Astrazeneca AZN:US USD 387M 0
Avrobio Inc AVRO:US USD 4K 0
Bristol Myers Squibb BMY:US USD 292M 0
Eli Lilly And LLY:US USD 594.1M 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Karyopharm Therapeutics KPTI:US USD 8K 0
Macrogenics MGNX:US USD 615K 0
Mirati Therapeutics MRTX:US USD 58K 2K
Nektar Therapeutics NKTR:US USD 19K 0
Novartis NOVN:VX USD 878.25M 11.75M
Novartis NVS:US USD 890M 0
Regeneron Pharmaceuticals REGN:US USD 100K 0
Sangamo Biosciences SGMO:US USD 1.62M 85K
Takeda 4502:JP JPY 1.68T 53M
Tg Therapeutics TGTX:US USD 145K 0
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Xencor XNCR:US USD 598K 0